摘要
目的研究阿仑膦酸钠片联合骨肽片治疗骨质疏松症伴疼痛的临床效果。方法整群选取2014年1月—2015年1月收治骨质疏松症伴疼痛患者110例,随机分为观察组(n=55)和对照组(n=55),对照组给予阿仑膦酸钠片口服治疗;观察组在此基础上加用骨肽片饭后口服,观察两组治疗效果及不良反应。结果观察组治疗后总有效率89.1%显著高于对照组74.5%(χ2=3.91,P<0.05);两组患者不良反应发生率对比差异无统计学意义(χ2=2.95,P>0.05)。结论阿仑膦酸钠片联合骨肽片治疗骨质疏松症伴疼痛疗效好,患者疼痛症状改善快,值得推广。
Objective To study the clinical effect of alendronate sodium tablets combined with ossotide tablets in the treatment of osteoporosis with pain. Methods 110 cases of patients having osteoporosis with pain admitted from January 2014 to January 2015 were selected and randomly divided into the observation group(55 cases) and the control group(n=55). The control group was given alendronate sodium tablets for treatment while the observation group received oral administration of ossotide tablets after meal based on the treatment of the control group. The curative effect and adverse reactions in the two groups were observed. Results In the observation group, the total efficiency was 89.1% which was significantly higher than 74.5%of the control group(χ2=3.91, P<0.05); The comparison of incidence of adverse reactions in the two groups of patients was of no significant difference and no statistical significance(χ2=2.95, P>0.05). Conclusion The curative effect of alendronate sodium tablets combined with ossotide tablets in the treatment of osteoporosis with pain is good with which the pain symptoms of patients are improved quickly, which is worthy to be popularized.
出处
《中外医疗》
2015年第29期120-121,共2页
China & Foreign Medical Treatment
关键词
阿仑膦酸钠片
骨肽片
骨质疏松症
疼痛
Alendronate sodium tablets
Ossotide tablets
Osteoporosis
Pain
